期刊文献+

卵巢癌中TGF-β/Smads信号通路的功能研究 被引量:3

Functional Study on TGF-β/Smads Signaling Pathway in Human Ovarian Cancer Cells
暂未订购
导出
摘要 为探讨卵巢癌细胞中TGF β的信号传导情况及TGF β/Smads信号通路各组分在卵巢癌发生中的作用 ,采用MTT和活细胞计数方法研究了TGF β1对卵巢癌细胞系HO 8910、HO 8910PM及SKOV3的生长抑制作用 ;并应用RT PCR、荧光免疫组化等方法研究了TGF β/Smads传导通路中各组分的表达和定位以及TGF β1刺激前后Smad7和P Smad2定位及表达的变化。结果显示 ,TGF β1对细胞系SKOV3没有生长抑制作用 ,而SKOV3细胞表达了TGF β/Smads信号通路中的所有已知成分。且 3种卵巢癌细胞在TGF β1刺激后Smad7mRNA瞬时表达增加 ,Smad7蛋白表达亦增加并由胞核转位到胞浆 ,P Smad2由胞浆转位到胞核。结果表明TGF β/Smads信号传导通路在卵巢癌细胞HO 8910、HO 8910PM和SKOV3中是完整的 ,SKOV3细胞逃逸TGF β介导的生长抑制作用可能是由于TGF Resistance to the growth inhibitory effects of transforming growth factor-β(TGF-β) is a characteristic of many transformed cells. The purpose of this study was to determine the response of ovarian cancer cells to TGF-β1 and to investigate the roles of components of the TGF-β/Smads signaling pathway in carcinogenesis of ovarian cancer. Three ovarian cancer cell lines,HO-8910,HO-8910PM and SKOV3,were treated with TGF-β1 and assayed for growth response by MTT assay. Furthermore,expression and subcellular localization of the components of TGF-β/Smads signaling pathway in these cell lines in the absence or presence of TGF-β1 were determined by RT-PCR and immunofluorescence analysis. We found that proliferation of SKOV3 cell was not significantly inhibited by TGF-β1 while it expressed all components of the TGF-β/Smads signaling pathway. After exposure to TGF-β1,Smad7 protein in SKOV3 increased transiently and translocated to cytoplasm from nucleus while P-Smad2 translocated into nucleus from cytoplasm. Taken together,the results suggested that the TGF-β/Smads signaling pathway remained functional in human ovarian cancer cells,HO-8910,HO-8910PM and SKOV3,and the abnormalities of the downstream effectors of Smads proteins might contribute to the resistance of SKOV3 cell to TGF-β1.
出处 《Acta Genetica Sinica》 SCIE CAS CSCD 北大核心 2004年第8期759-765,共7页
基金 高等学校优秀青年教师教学科研奖励计划 国家自然科学基金 (编号 :3 0 3 70 783 ) 黑龙江省科学技术计划攻关项目 (编号 :GB0 3C60 1-1)资助~~
关键词 转化生长因子-β(TGF-β) SMADS 卵巢癌 TGF-β Smads ovarian cancer
  • 相关文献

参考文献13

  • 1[1]Jeremy N,Anita J,Xiao F W. Transforming growth factor-β signaling in cancer.Microscopy Res and Tech,2001,52:363~373.
  • 2[2]Chang J,Park K,Bang Y J,Kim W S,Kim D,Kim S J. Expression of transforming growth factor beta type II receptor reducestumorigenicity in human gastric cancer cells.Cancer Res,1997,57(14):2856~2859.
  • 3[3]Grady W M,Rajput A,Myeroff L,Liu D F,Kwon K,Willis J,Markowitz S. Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.Cancer Res,1998,58(14):3101~3104.
  • 4[4]Rodriguez G C,Nagarsheth N P,Lee K L,Bentley R C,Walmer D K,Cline M,Whitaker R S,Isner P,Berchuck A,Dodge R K,Hughes C L. Progestin induction of apoptosis in the macaque ovarian epithelium is associated with up-regulation of transforming growth factor β.Gynecol Oncol,2001,80:276~281.
  • 5[5]Yamada S D,Baldwin R L,Karlan B Y. Ovarian carcinoma cell cultures are resistant to TGF-β1 mediated growth inhibition despite expression of functional receptors.Gynecol Oncol.,1999,75:72~77.
  • 6[6]Chen T,Triplett J,Dehner B,Hurst B,Colligan B,Pemberton J,Graff J R,Carter J H. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.Cancer Res,2001,61(12):4679~4682.
  • 7[7]Lynch M A,Nakashima R,Song H,DeGroff V L,Wang D,Enomoto T,Weghorst C M. Mutational analysis of the transforming growth factor beta receptor type Ⅱ gene in human ovarian carcinoma.Cancer Res,1998,58(19):4227~4232.
  • 8[8]Lesley D,Elizabeth J and ,Mark W. TGF β-induced smad signaling remain intact in primary human ovarian cancer cells.Endocrinology,2002,143(4):1174~1181.
  • 9[9]Francis-Thickpenny K M,Richardson D M,van Ee C C,Love D R,Winship I M,Baguley B C,Chenevix-Trench G,Shelling A N. Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma. Br J Cancer,2001,85(5):687~691.
  • 10[11]Wang B,Hao J,Jones S C,Yee M S,Roth J C,Dixon I M. Decreased Smad 7 expression contributes to cardiac fibrosis in the infracted rat heart.Am J Physiol Heart Circ Physiol,2002,282(5):H1685~1696.

同被引文献70

  • 1高中玉,林子豪,袁相斌.TGF-β基因表达调控的新进展[J].国外医学(生理病理科学与临床分册),2004,24(3):253-256. 被引量:2
  • 2Kluger Y, Basri R, Chang JT, Gerstein M. Spectral biclustering of microarray data: coclustering genes and conditions. Genome Research, 2003, 13(4): 703-716.
  • 3Lapointe J, Li CD, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, Ekman P, DeMarzo AM, Tibshirani R, Botstein D, Brown PO, Brooks JD, Pollack JR. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA, 2004, 101(3): 811-816.
  • 4Segal E, Shapira M, Regev A, Pe'er D, Botstein D, Koller D, Friedman N. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet, 2003, 34(2): 166-176.
  • 5Koumakpayi IH, Le Page C, Mes-Masson AM, Saad F. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer. Br J Cancer, 2010, 102(7): 1163-1173.
  • 6Ma SG, Kosorok MR. Identification of differential gene pathways with principal component analysis. Bioinformatics, 2009, 25(7): 882-889.
  • 7Huang DS, Zheng CH. Independent component analysis-based penalized discriminant method for tumor classification using gene expression data. Bioinformatics, 2006, 22(15): 1855-1862.
  • 8Sandberg R, Ernberg I. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci USA, 2005, 102(6): 2052-2057.
  • 9Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, Yaffe MB. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science, 2005, 310(5754): 1646-1653.
  • 10Bild AH, Yao G; Chang JT, Wang QL, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA Jr, Marks JR, Dressman HK, West M, Nevins JR. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature, 2006, 439(7074): 353-357.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部